1-4 of 4
Kanya Rajangam, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Study of NKX101, an Allogeneic CAR Natural Killer (NK) Cell Therapy, in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndrome (MDS)

Carlos Bachier, MD, Gautam Borthakur, MD, Chitra Hosing, MD, William Blum, MD, Marcello Rotta, MD, Paulius Ojeras, Brian Barnett, MD, Kanya Rajangam, MD PhD, Navneet S. Majhail, MD MS, Sarah Nikiforow, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-134625
Published: 2020
Journal Articles

Cardiac Event Rates in Patients with Newly Diagnosed and Relapsed Multiple Myeloma in US Clinical Practice.

Kristin D Kistler, PhD, Kanya Rajangam, MD, PhD, Gerald Faich, MD, Stephan Lanes, PhD
Journal: Blood
Blood (2012) 120 (21): 2916.
https://doi.org/10.1182/blood.V120.21.2916.2916
Published: 2012
Journal Articles

Cardiac and Pulmonary Safety Profile of Single-Agent Carfilzomib From Four Phase 2 Studies in Patients with Relapsed and/or Refractory Multiple Myeloma

Sagar Lonial, MD, Ruben Niesvizky, MD, Leanne McCulloch, PharmD, Kanya Rajangam, MD, PhD, Ravi Vij, MD
Journal: Blood
Blood (2012) 120 (21): 4037.
https://doi.org/10.1182/blood.V120.21.4037.4037
Published: 2012
Journal Articles

A Phase I Dose Expansion Cohort Study of the Safety, Pharmacokinetics and Pharmacodynamics of SAR245409 (S09), An Orally Administered PI3K/mTOR Inhibitor, in Patients with Lymphoma

Kyriakos P Papadopoulos, MD, Pau Abrisqueta, MD, Glenda Chambers, BSN, RN, OCN, CCRC, Drew Rasco, MD, Amita Patnaik, Josep Tabernero, MD, Kanya Rajangam, MD, PhD, Kevin Rockich, Coumaran Egile, Adrianne Kelly, MD, Yi Xu, Joanne Lager, MD, Julie M Vose, MD
Journal: Blood
Blood (2011) 118 (21): 1608.
https://doi.org/10.1182/blood.V118.21.1608.1608
Published: 2011